Norwegian guidelines for pharmacoeconomic analysis in connection with applications for reimbursement
ثبت نشده
چکیده
• 1. Purpose • 2. Specification of requirements • 3. Introduction to the analysis • 4. Description of the drug and its use • 5. Choice of basis for comparison • 6. Time perspective of the analysis • 7. Data collection methods • 8. Analysis methods • 9. Use of clinical and economical data from abroad • 10. Cost perspective of the analysis • 11. Costs • 12. Discounting • 13. Results • 14. Sensitivity analysis • 15. Discussion and conclusion • 16. List of references • 17. Summary of analysis structure
منابع مشابه
Success Rate of Including Medicines to The Reimbursement System In Slovakia.
The analysis can help to understand the most important criteria in local price and reimbursement decision making process. The success rate for inclusion of new drugs is relatively high in Slovakia, but the majority of drugs included to the Reimbursement List do not require higher public expenditures. The most frequent reasons for non-inclusion of a drug to the Reimbursement List were different ...
متن کاملImpact Of Pharmacoeconomic Guidelines on the Reimbursement Process of Medicines In Serbia In 2014.
METHODS We investigated the budget impact analysis made by pharmaceutical companies, in the period September 2013 to June 2014. Quality was assessed using the criteria for pharmacoeconomic evaluations from the in the most recent ISPOR guidelines and the Serbian pharmacoeconomic guidelines. The impact of the introduction of the new rulebook was assessed by comparing the period following its intr...
متن کامل“Budget Impact Analyses”: a practical policy making tool for drug reimbursement decisions
Increasing accessibility and affordability of healthcare services has been considered as an important policy objective since the beginning of 1980s in Iran. However, current 60- 70% health care out-of-pocket payments create a barrier to an equal access to quality health services, especially in terms of new medicines which affects equity issues and "health" in Iran. Currently, health insurance o...
متن کامل“Budget Impact Analyses”: a practical policy making tool for drug reimbursement decisions
Increasing accessibility and affordability of healthcare services has been considered as an important policy objective since the beginning of 1980s in Iran. However, current 60- 70% health care out-of-pocket payments create a barrier to an equal access to quality health services, especially in terms of new medicines which affects equity issues and "health" in Iran. Currently, health insurance o...
متن کاملCritical Analysis of Pricing and Reimbursement Process on The Basis of New Indroduced Pharmacoeconomic Guidelines In Bulgaria.
INTRODUCTION The pricing and reimbursement process in Bulgaria is based on different approaches implemented by NCPR among which is external and internal reference pricing A pharmacoeconomic guidelines (PE) with a HTA approach for assessment of submitted dossiers was implemented y the competent authority (CA) in Bulgaria in April 2015. Requirements for efficacy, safety, benefits, adverse events,...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2008